Worst-Performing Biotech Stocks - Spectrum Pharmaceuticals (SPPI), Geron (GERN), Newmont Mining (NEM)

New York, NY -- (SBWIRE) -- 03/14/2013 -- StockRunway.com issues special report on the Worst-Performing Biotech Stocks – Spectrum Pharmaceuticals, Inc (NASDAQ:SPPI), Geron Corporation (NASDAQ:GERN), Newmont Mining Corp (NYSE:NEM)

Spectrum Pharmaceuticals, Inc (NASDAQ:SPPI) shares went -37.33% down and closed at $7.79 in the last trading session as the company predict a sharp decline in annual sales as hospitals increasingly opt for a generic colon cancer treatment over its biggest-selling drug, Fusilev.

In the last month, Spectrum had predicted sales to rise this year but on Tuesday, it said that total revenue is expected to fall in a range of $160 million-$180 million in 2013. Back in 2012, Fusilev generated revenue of $204.3 million, representing nearly 80 percent of the company's product sales. Spectrum now predicts Fusilev sales to range between $80 million and $90 million in 2013.

Has SPPI Found The Bottom and Ready To Move Up? Find Out Here

Its overall traded volume was 22.56 million shares. The stock’s opening price was $7.81, hitting the day high price of $8.26 and day low of $7.72. SPPI has earnings per share of $1.46 and its price to earnings ratio was 5.34. The company has 24.03% returns on assets, 40.02% returns on equity and its return on investments is 32.59%.

Geron Corporation (NASDAQ:GERN) dropped -9.15% to close at $1.29 and its total volume in the last trading session was 2.53 million shares after Brian Klein of Stifel Nicolaus downgraded the stock from Hold to Sell.

The company recently posted a loss of $0.12 per share for the fourth quarter, surpassing the consensus estimate of ($0.14) by $0.02. The company reported sales of $0.69 million for the quarter, higher from the consensus estimate of $0.51 million.

Has GERN Found The Bottom And Ready To Gain Momentum? Find Out Here

In last 52 weeks, high hit was $2.99 and low price in that period was $1.24. The company has outstanding shares of 130.76million with the total market cap of $168.67million and its beta value stands at 1.02 times. It has current ratio of 9.15.

Newmont Mining Corp (NYSE:NEM) fell -0.97% and closed at $44.75 with the total traded volume of 5.17 million shares after Jefferies Group reaffirmed its hold rating on the stock. Its opening price was $45.02 and its shares traded within the range of $42.95-$64.43.

Why Should Investors Buy NEM After the Recent Fall? Just Go Here and Find Out

This company has earnings per share of $0.40 with the net profit margin of 6.58% and operating margin of 13.10%. The company now has market cap of about $22.22 billion.

About StockRunway.com
StockRunway.com is an Elite Financial Stock website catering to individual investors, fund managers, investment bankers and equity analysts. Whether you're new to penny stocks or a seasoned veteran, you'll find all the information you will need right here! Our research is a remarkable educational tool for everyone to utilize.

Sign up TODAY and join the vast amount of investors already benefiting from the best free alerts from StockRunway's service today!

Disclaimer
This report/release/advertisement is a commercial advertisement and is for general information purposes only. Never invest in any stock featured on our site, Press Releases or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our email list. PLEASE NOTE WELL: StockRunway.com and its employees are not a Registered Investment Advisor, Broker Dealer or a member of any association for other research providers in any jurisdiction whatsoever. Read our Full Disclaimer by visiting our website.

Read Our Full Disclaimer at: http://www.stockrunway.com/disclaimer/